跳至主要内容
临床试验/NCT05246722
NCT05246722尚未招募不适用

Registry Study of Pharmacotherapy and Clinical Outcomes in Elderly Patients With Coronary Heart Disease

Beijing Anzhen Hospital0 个研究点目标入组 15,000 人开始时间: 2022年2月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
15,000
主要终点
main adverse cardiovascular and cerebrovascular events (MACCE)

研究概览

简要总结

A registry study on drug therapy and clinical outcomes in elderly patients with coronary heart disease

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Informed consent has been signed
  • Patients diagnosed in our hospital with coronary heart disease
  • Age ≥65 years

排除标准

  • Severe lack of important information such as history of previous medication, history of previous disease, history of surgery.
  • Mental disorders, or inability to communicate effectively with researchers, or failure to comply with research protocols.

结局指标

主要结局

main adverse cardiovascular and cerebrovascular events (MACCE)

时间窗: up to 3 years

MACCE will be defined as all-cause death, non-fatal stroke, non-fatal myocardial infarction (MI), and ischemic-driven revascularization

次要结局

  • Adverse drug reaction(up to 3 years)

研究者

发起方
Beijing Anzhen Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Lin Yang

Director of pharmacy department of Beijing Anzhen Hospital

Beijing Anzhen Hospital

相似试验